Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance

SIMPLE SUMMARY: Bevacizumab mediated anti-angiogenesis provides a new chance of survival for patients with a tumor. However, most patients have acquired bevacizumab resistance after continuous treatment, and there is no available clinical therapy to overcome drug resistance. In this study, we analyz...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Nannan, Liang, Xue, Fan, Buxi, Zhao, Chen, Shen, Beiyu, Ji, Xuemei, Liu, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688485/
https://www.ncbi.nlm.nih.gov/pubmed/36428773
http://dx.doi.org/10.3390/cancers14225681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688485/
https://www.ncbi.nlm.nih.gov/pubmed/36428773
http://dx.doi.org/10.3390/cancers14225681

Ejemplares similares